🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study aims to evaluate the safety, tolerability and effectiveness of n...
Status
Unknown
Location
Border Medical Oncology
Start Date
2017-10-19
Trial ID
NCT03177239
Treatments Being Tested
Immunotherapy + Radiation in Resectable Soft Tissue Sarcoma...
Status
Completed
Location
James P. Wilmot Cancer Center at University of Rochester Medical Center
Start Date
2018-07-17
Trial ID
NCT03463408
Treatments Being Tested
The purpose of this study is to test the side effects of an investigational...
Status
Completed
Location
H. Lee Moffitt Cancer Center and Research Institute
Start Date
2010-08-13
Trial ID
NCT01176474
This is an open label, dose-seeking phase 1/2 study using escalating doses ...
Status
Recruiting
Location
Sarcoma Oncology Research Center
Start Date
2017-04-13
Trial ID
NCT03138161
Treatments Being Tested
This open label, randomized study will evaluate safety and tolerability of ...
Status
Withdrawn
Location
Partner Therapeutics - No Currently Active Sites
Start Date
2024-01
Trial ID
NCT05284214
Treatments Being Tested
The hypothesis of the CA048-001 Phase 1 clinical trial is targeting multipl...
Status
Completed
Location
Local Institution
Start Date
2020-09-22
Trial ID
NCT04132817
Treatments Being Tested
This phase I trial tests the safety and effectiveness of nivolumab and ipil...
Status
Recruiting
Location
City of Hope Medical Center
Start Date
2026-03-23
Trial ID
NCT07128680
Cancer drugs which target the effects of abnormal gene changes are called '...
Status
Recruiting
Location
Cross Cancer Institute
Start Date
2018-03-23
Trial ID
NCT03297606
This phase Ib trial studies the side effects of nivolumab and to see how we...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2019-07-16
Trial ID
NCT03816345
Malignant melanoma is a leading cause of death from cutaneous malignancies,...
Status
Completed
Location
Southern Cancer Center
Start Date
2014-10-31
Trial ID
NCT02259231